Amphastar Pharmaceuticals, Inc. (AMPH) Barclays 28th Annual Global Healthcare Conference March 10, 2026 8:00 PM EDT
Company Participants
William Peters – CFO, Executive VP of Finance, Treasurer & Director
Dan Dischner – Senior Vice President of Human Resources & Corporate Communication
Conference Call Participants
Glen Santangelo – Barclays Bank PLC, Research Division
Presentation
Glen Santangelo
Barclays Bank PLC, Research Division
All right. Well, thank you. Good afternoon, everybody. Thank you for joining us. We’re very excited to be hosting Amphastar Pharmaceuticals. To my right is Bill Peters, the CFO; and to his right is Dan Dischner, who’s in charge of the Corporate Communications and some other things at Amphastar.
For those of you who don’t know me, I’ll introduce myself. I’m Glen Santangelo. I’m the analyst at Barclays that covers the spec pharma and animal health space, among some other things. And we’re excited to have you both here today. So thank you for joining us.
William Peters
CFO, Executive VP of Finance, Treasurer & Director
Thank you for having us.
Dan Dischner
Senior Vice President of Human Resources & Corporate Communication
thanks for having us.
Question-and-Answer Session
Glen Santangelo
Barclays Bank PLC, Research Division
All right. Well, why don’t we just sort of dive right into it. Bill, I think a great place to start is going to be talking about some of the highlights from the fourth quarter and really fiscal ’25, maybe more broadly. Obviously, there were some positives in the year that I think we can discuss. But to be balanced, I think maybe even in the fourth quarter, there are a couple of products that maybe fell a little bit short of your expectations. And so why don’t you maybe to level set us, just put all that in perspective and then we can sort of dive right in. And as part of that, I don’t know there, you can emphasize maybe some
